Hypericin
Hypericin, also known as SGX301, is a novel, first-in-class photodynamic therapy using a potent photosensitizer, synthetic hypericin, that is topically applied and activated by safe visible fluorescent light. This treatment avoids the risk of secondary malignancies (including melanoma) inherent with the frequently employed DNA-damaging chemotherapeutic drugs and other photodynamic therapies that are dependent on ultraviolet A (UVA) light exposure.
Product Specifications
CAS Number
548-04-9
Product Name Alternative
SGX301 | SGX-301 | NSC 622946 | hypericin
Purity
>98% (HPLC)
Solubility
DMSO : 6.2 mg/mL 12.29 mM
Smiles
CC1=CC (=C2C3=C1C4=C5C (=C (C=C4C) O) C (=O) C6=C (C=C (C7=C6C5=C3C8=C7C (=CC (=C8C2=O) O) O) O) O) O
Molecular Formula
C30H16O8
Molecular Weight
504.45
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
1,3,4,6,8,13-Hexahydroxy-10,11-dimethylphenanthro (1,10,9,8-opqra) perylene-7,14-dione
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Research Grade Anti-Human TGFa/TGF-alpha Antibody (LY3016859)
Research Grade Anti-Human TGFa/TGF-alpha Antibody (LY3016859)
Research Grade Anti-Human TGFa/TGF-alpha Antibody (LY3016859)
PSIP1 Recombinant Antibody, AbBy Fluor™ 680 Conjugated